SQZ Biotechnologies Appoints Marshelle Smith Warren, M.D., as Chief Medical Officer

Author's Avatar
May 31, 2022

SQZ+Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that it has appointed Marshelle Smith Warren, M.D., as Chief Medical Officer. Dr. Warren will report to the CEO and lead the company’s clinical development, clinical operations, translational medicine, and regulatory affairs functions.